About RondinX
RondinX is a Healthcare company based in Tel Aviv (Israel) founded in 2015, and was acquired by BiomX in December 2017. It operates as a microbiome drug discovery platform for therapeutics and diagnostics is offered. The company was acqui-hired. Its focus areas include Life Sciences, Clinical Genomics, Sequencing Based and Microbial Testing. Its competitors include Pendulum, Depixus, Genomics, Seven Bridges Genomics and Hexagon Bio and 5 more; 10 of its 10 listed competitors have raised funding.
Company details
RondinX was founded in 2015 in Tel Aviv, Israel, as a microbiome analysis company. A proprietary cloud-based computational pipeline, licensed from YEDA, is utilized to derive strain-level insights from metagenomics data. Bioinformatics, systems biology, machine learning, and data mining are leveraged to identify diagnostic and therapeutic targets in the bacterial ecosystem. Solutions for microbiome therapeutics and companion diagnostics are developed through this platform.
- Headquarters Tel Aviv, Israel
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website rondinx.com
- Acquired by BiomX (Dec 2017)
Investors in RondinX
RondinX has secured backing from 1 investor. Prominent investors backing the company include BiomX.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Microbiome therapeutics are developed for dysbiosis-linked diseases. | 2015 | biomx.com | Ness Ziona, Israel |
Investor details for RondinX
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of RondinX
2 dated milestones of RondinX across 2 years, from founding to its latest funding, stage changes and deals.
- Founded RondinX is founded.
- Exit Acquired by BiomX.
Competitors of RondinX
RondinX has 10 listed competitors in our database, 10 of them funded. They include Pendulum, Depixus, Genomics, Seven Bridges Genomics and Hexagon Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pendulumlife.com | 2012 | San Francisco, United States | $109.5M | 55 | Pendulum is focused on developing advanced probiotic solutions. | |
| depixus.com | 2012 | Paris, France | $34.52M | – | Single-molecule genetic and epigenetic sequencing solutions are provided. | |
| genomics.com | 2014 | Oxford, United Kingdom | $115.54M | – | Genomic risk assessment and prevention platform is provided. | |
| sevenbridges.com | 2009 | Cambridge, United States | $113M | 112 | Cloud-based platform to analyze, store, and act on genomic data. | |
| hexagonbio.com | 2017 | Menlo Park, United States | $205.6M | 34 | Bioinformatics tools are provided for analyzing microbial genomic sequencing data. | |
| bcplatforms.com | 1997 | Zurich, Switzerland | $45.44M | 8 | Platforms for genomic data analysis and management are provided. | |
| ingenuity.com | 1998 | Redwood, United States | $20.4M | 30 | Genomic data is analyzed and interpreted via web-based applications. | |
| deepgenomics.com | 2015 | Toronto, Canada | $237.96M | – | Machine learning is utilized for precision medicine and genetic diagnostics. | |
| envisagenics.com | 2014 | Long Island, United States | $46.78M | – | RNA splicing therapeutics are discovered and developed through AI-driven biotechnology. | |
| eaglegenomics.com | 2008 | Cambridge, United Kingdom | $38.73M | – | Developer of cloud-based software solutions for genomic analysis |
Detailed competitors of RondinX
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as RondinX (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Rondinx
Complete news archive for RondinX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RondinX
RondinX was founded in 2015.
RondinX is headquartered in Tel Aviv, Israel.
RondinX was founded in 2015 in Tel Aviv, Israel, as a microbiome analysis company. A proprietary cloud-based computational pipeline, licensed from YEDA, is utilized to derive strain-level insights from metagenomics data. Bioinformatics, systems biology, machine learning, and data mining are leveraged to identify diagnostic and therapeutic targets in the bacterial ecosystem. Solutions for microbiome therapeutics and companion diagnostics are developed through this platform.
RondinX's top competitors include Pendulum, Eagle Genomics and Depixus.
RondinX has 1 investor. Key investors include BiomX.
Yes. RondinX was acquired by BiomX in December 2017.